Home › Acute myeloïde leukemie › Ohio › Cincinnati
Acute myeloïde leukemie klinische studies in Cincinnati, OH
20 studies voor Acute myeloïde leukemie zoeken deelnemers op locaties in en rond Cincinnati (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- en nog 3
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruterenObservatieonderzoek
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RekruterenFase 3
- Oncology Hematology Care, Cincinnati
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
RekruterenFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruterenFase 3
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
RekruterenObservatieonderzoek
- University of Cincinnati, Cincinnati
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
RekruterenFase 3
- US-Cincinnati OH-CINCY, Cincinnati
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
RekruterenFase 3
- US-Cincinnati OH-CINCY, Cincinnati
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
RekruterenFase 1
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mijl verwijderd
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruterenFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
RekruterenFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
RekruterenFase 3
- University of Cincinnati Medical Center (University Hospital), Cincinnati
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruterenObservatieonderzoek
- Cincinnati Children's Hospital, Cincinnati
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RekruterenFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
RekruterenFase 1
- Cincinnati Children's Hospital, Cincinnati
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
RekruterenFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
RekruterenFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
RekruterenFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
RekruterenFase 1
- Oncology Hematology Care, Cincinnati
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
RekruterenFase 1
- University of Cincinnati, Cincinnati
Acute myeloïde leukemie studies in andere steden
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Baldwin Park, CA40 studies
- Seattle, WA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA30 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
Andere studies in Cincinnati
- Niet-kleincellige longkanker35 studies
- Kanker (alle vormen)27 studies
- Borstkanker25 studies
- Hartfalen24 studies
- Colorectale kanker21 studies
- Metastatische kanker20 studies
- Eierstokkanker19 studies
- Longkanker19 studies
- Obesitas19 studies
- Prostaatkanker18 studies
- Multipel myeloom17 studies
- Melanoom17 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.